TrialDiabetologia2004

Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.

N Katakami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.